BAA-FY24C3CP5-understanding heterogeneity in preferences for clinical trial participation in diverse patient populations.

Active Definitive Contract Awarded Last action

Contract number
75F40124C00134
Awardee
Awarding agency
Obligated
$1,299,218

Award facts

Contract value 100% obligated
$1,299,218.00 Current and potential, with all options
Completion date 66% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Time and Materials
Place of performance
Cape Fear, NC 28401, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00008 $0
Other Administrative Action P00007 · EO 14398 - the purpose of this modification is to update the deliverables timetable for phase II activities to reflect the project timeline. $0
Exercise an Option P00006 $801,639
Other Administrative Action P00005 · No cost modification to change the period of performance end date to 04/13/2026. $0
Other Administrative Action P00004 · COR change. $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 · No cost modification to change the period of performance end date to february 02, 2026. $0
Other Administrative Action P00001 · MOD P00001 - to change contract type for BAA-FY24C3CP5-understanding heterogeneity in preferences for clinical trial participation in diverse patient… $0
Original award $497,579

About this award

The Food and Drug Administration awarded a $1.299 million definitive contract to PPD Development LP for research on understanding heterogeneity in preferences for clinical trial participation in diverse patient populations on September 24, 2024, under a time-and-materials pricing structure with no set-aside.

The originating solicitation (BAA-FY24C3CP5) funds Phase II activities, with a recent modification updating the deliverables timetable to reflect the project timeline. Place of performance is Cape Fear, NC. The contract runs through November 22, 2027. In FY2025, the contract invoked $242 thousand and 0.4 FTEs, with PPD self-performing all work and no subcontractors engaged.

Quick answers

Who was awarded contract 75F40124C00134?

75F40124C00134 was awarded to PPD Development LP by Food and Drug Administration (Department of Health and Human Services) on September 24, 2024.

How much is contract 75F40124C00134 worth?

The government has obligated $1,299,218 on 75F40124C00134.

Was contract 75F40124C00134 competed?

The extent of competition for 75F40124C00134 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award